Sominex Max Tablet
Product Images NDC 63029-505

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Sominex Max (NDC 63029-505). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medtech Products Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panelmaximum Formulasominexnighttime Sleep-aid Diphenhydramine HCl16 Tablets (Sominex Max 01)

Principal Display Panelmaximum Formulasominexnighttime Sleep-aid Diphenhydramine HCl16 Tablets (Sominex Max 01)
Drug Facts is a medication intended for reducing insomnia and help in sleeping. It contains diphenhydramine, which is capable of reducing the time needed to fall asleep. Its active ingredient is Diphentycranine G150 mg. It comes with overdose warnings; it is essential to take it as directed by your doctor or as needed. The drug comes with a Tamper Evident Feature, which ensures that the product remains protected in a sealed blister. It should not be taken in children under 12 years without a doctor's prescription. If you have severe breathing issues and enlarged prostate, consult your doctor before taking this medication. Additionally, the product should not be taken with alcohol or other antihistamines. Continuous usage of this drug for more than two weeks is prohibited, and for pregnant women and breastfeeding, it is essential to consult a health professional before using it.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.